Type
. Anti-Mycobacterium leprae monoclonal antibodies cross-react with human skin: an alternative explanation for the immune responses in leprosy. The Journal of investigative dermatology. 1990;94(5):685-8.
Type
. Identification and characterization of antigenic determinants of Mycobacterium leprae that react with antibodies in sera of leprosy patients. Infection and immunity. 1990;58(5):1327-36.
Type
. Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America. 1990;87(3):973-7.
Type
. Slit-skin smear in leprosy. International journal of dermatology. 1990;29(1):9-16.
Type
. Histopathological findings in the iris of dapsone treated leprosy patients. The British journal of ophthalmology [Internet]. 1990;74(1):14-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1041970/pdf/brjopthal00575-0022.pdf
Type
. The effect of tetanus toxoid in leprosy patients. Indian journal of leprosy. 1990;62(1):104-8.
Type
. Sporadic ulcero-osteolytic neuropathy in Blacks. A report of two cases. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1975;49(28):1139-41.
Type
. Leprosy: what is being "eliminated"?. Bulletin of the World Health Organization [Internet]. 2007;85(1):2. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636219/pdf/06-039206.pdf
Type
. Review of ocular leprosy. Journal of the Indian Medical Association. 2006;104(7):401-3, 407.
Type
. Mechanism of thioamide drug action against tuberculosis and leprosy. The Journal of experimental medicine. 2007;204(1):73-8.